These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 20727015

  • 1. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I.
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [Abstract] [Full Text] [Related]

  • 2. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 3. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P.
    N Engl J Med; 2000 Feb 10; 342(6):365-73. PubMed ID: 10666426
    [Abstract] [Full Text] [Related]

  • 5. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D, Ehlert F, Sherrid M.
    Anadolu Kardiyol Derg; 2006 Dec 10; 6 Suppl 2():55-60. PubMed ID: 17162272
    [Abstract] [Full Text] [Related]

  • 6. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H, Rigopoulos A.
    Paediatr Drugs; 2003 Dec 10; 5(10):663-72. PubMed ID: 14510624
    [Abstract] [Full Text] [Related]

  • 7. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.
    Rev Esp Cardiol; 2006 Jun 10; 59(6):537-44. PubMed ID: 16790196
    [Abstract] [Full Text] [Related]

  • 8. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS, Link MS.
    J Am Coll Cardiol; 2013 Apr 09; 61(14):1527-35. PubMed ID: 23500286
    [Abstract] [Full Text] [Related]

  • 9. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA.
    Europace; 2009 May 09; 11(5):643-9. PubMed ID: 19164362
    [Abstract] [Full Text] [Related]

  • 10. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.
    Herz; 2005 Mar 09; 30(2):102-10. PubMed ID: 15875098
    [Abstract] [Full Text] [Related]

  • 11. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.
    Heart; 2009 May 09; 95(9):709-14. PubMed ID: 19282314
    [Abstract] [Full Text] [Related]

  • 12. Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America?
    Östman-Smith I, Rossano JW, Shaddy RE.
    Curr Opin Cardiol; 2013 Mar 09; 28(2):130-8. PubMed ID: 23348710
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N, de Chillou C, Aliot E, McKenna WJ.
    Arch Mal Coeur Vaiss; 1999 Apr 09; 92 Spec No 1():65-73. PubMed ID: 10326160
    [Abstract] [Full Text] [Related]

  • 14. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ.
    J Insur Med; 2002 Apr 09; 34(1):43-60. PubMed ID: 15303593
    [Abstract] [Full Text] [Related]

  • 15. [Prevention of sudden death in hypertrophic cardiomyopathy (HCM ): implanted defibrillators in HCM].
    Maron BJ, Spirito P.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr 09; 37(4):297-302. PubMed ID: 19791462
    [Abstract] [Full Text] [Related]

  • 16. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ, Kleinebenne A.
    Herz; 1985 Apr 09; 10(2):91-101. PubMed ID: 2580767
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F, Olivotto I.
    G Ital Cardiol; 1999 Oct 09; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract] [Full Text] [Related]

  • 18. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA, Rossano JW, Smith EO, Cannon B, Clunie SK, Gates C, Jefferies JL, Kim JJ, Price JF, Dreyer WJ, Towbin JA, Denfield SW.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):250-4. PubMed ID: 19589438
    [Abstract] [Full Text] [Related]

  • 19. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK, Camm AJ.
    Arch Mal Coeur Vaiss; 1996 Feb 14; 89 Spec No 1():37-49. PubMed ID: 8734163
    [Abstract] [Full Text] [Related]

  • 20. Prevention of sudden cardiac death.
    Goldberger JJ.
    Heart Dis; 2000 Feb 14; 2(4):305-13. PubMed ID: 11728274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.